Opus Investment Management’s Pfizer PFE Stock Holding History

Opus Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-78,000	Closed	-$2.86M	–	67
2023 Q2	$2.86M	Hold	78,000	–	–	1.03%	38
2023 Q1	$3.18M	Hold	78,000	–	–	1.15%	39
2022 Q4	$4M	Sell	78,000 -46,000	-37%	-$2.21M	1.42%	32
2022 Q3	$5.43M	Hold	124,000	–	–	1.26%	15
2022 Q2	$6.5M	Hold	124,000	–	–	1.41%	10
2022 Q1	$6.42M	Hold	124,000	–	–	0.99%	22
2021 Q4	$7.32M	Sell	124,000 -8,000	-6%	-$396K	1.05%	16
2021 Q3	$5.68M	Hold	132,000	–	–	0.87%	30
2021 Q2	$5.17M	Hold	132,000	–	–	0.78%	34
2021 Q1	$4.78M	Sell	132,000 -7,500	-5%	-$266K	0.7%	40
2020 Q4	$5.13M	Sell	139,500 -15,438	-10%	-$566K	0.8%	37
2020 Q3	$5.39M	Hold	154,938	–	–	1.02%	31
2020 Q2	$4.81M	Hold	154,938	–	–	0.97%	33
2020 Q1	$4.8M	Sell	154,938 -1,581	-1%	-$53.9K	1.01%	24
2019 Q4	$5.82M	Hold	156,519	–	–	0.95%	23
2019 Q3	$5.34M	Buy	156,519 +17,391	+13%	+$632K	0.93%	30
2019 Q2	$5.72M	Hold	139,128	–	–	1.08%	16
2019 Q1	$5.61M	Hold	139,128	–	–	1.11%	18
2018 Q4	$5.76M	Sell	139,128 -8,432	-6%	-$350K	1.24%	13
2018 Q3	$6.17M	Sell	147,560 -42,160	-22%	-$1.62M	1.07%	13
2018 Q2	$6.53M	Hold	189,720	–	–	1.18%	6
2018 Q1	$6.39M	Hold	189,720	–	–	1.17%	8
2017 Q4	$6.52M	Hold	189,720	–	–	1.16%	15
2017 Q3	$6.43M	Sell	189,720 -8,432	-4%	-$271K	1.17%	13
2017 Q2	$6.32M	Hold	198,152	–	–	1.07%	12
2017 Q1	$6.43M	Hold	198,152	–	–	1.1%	17
2016 Q4	$6.11M	Hold	198,152	–	–	1.07%	17
2016 Q3	$6.37M	Buy	198,152 +8,432	+4%	+$282K	1.08%	14
2016 Q2	$6.34M	Hold	189,720	–	–	1.12%	11
2016 Q1	$5.33M	Buy	189,720 +33,728	+22%	+$963K	1.02%	16
2015 Q4	$4.78M	Buy	155,992 +31,620	+25%	+$995K	0.85%	34
2015 Q3	$3.71M	Hold	124,372	–	–	0.7%	51
2015 Q2	$3.96M	Buy	124,372 +10,540	+9%	+$344K	0.72%	46
2015 Q1	$3.76M	Sell	113,832 -42,160	-27%	-$1.34M	0.66%	40
2014 Q4	$4.61M	Hold	155,992	–	–	0.83%	20
2014 Q3	$4.38M	Hold	155,992	–	–	0.83%	22
2014 Q2	$4.39M	Buy	155,992 +40,052	+35%	+$1.14M	0.87%	28
2014 Q1	$3.53M	Buy	115,940 +42,160	+57%	+$1.26M	0.81%	41
2013 Q4	$2.14M	Sell	73,780 -42,160	-36%	-$1.23M	0.58%	56
2013 Q3	$3.16M	Hold	115,940	–	–	0.72%	47
2013 Q2	$3.08M	Buy	+115,940	New	+$3.2M	0.74%	48

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Opus Investment Management's PFE Position: Q3 2023 in Review

Opus Investment Management sold out of Pfizer (PFE) in Q3 2023, closing a stake of 78,000 shares — an estimated $2.86M sold.

Opus Investment Management first reported a position in PFE in Q2 2013 and held it in 41 quarters. The position peaked at $7.32M in Q4 2021. 2,926 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Opus Investment Management reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Opus Investment Management sold 78,000 Pfizer shares in Q3 2023, an estimated $2.86M.
Opus Investment Management first reported a position in Pfizer in Q2 2013 and held it in 41 quarters.
Opus Investment Management's Pfizer position peaked at $7.32M in Q4 2021.
2,926 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Opus Investment Management's 13F filing for Q3 2023, filed 8 Nov 2023.